Lung Cancer: Signs, Symptoms, Types, Treatment, and Prevention.

What Is Lung Cancer?

Lung cancer is a disease in which malignant cells form in the tissues of the lungs, usually in cells lining the airways. The lungs are responsible for bringing oxygen into the body and removing carbon dioxide when you breathe. Cancer can develop in different parts of the lung and may eventually spread to nearby lymph nodes or other parts of the body.

There are two main types of lung cancer:

• Non-small cell lung cancer (NSCLC): The most common category of lung cancer.
• Small cell lung cancer (SCLC): A less common type that tends to grow and spread more quickly.

The specific type and stage of cancer are important when determining the most appropriate treatment approach.

Types of Lung Cancer

Non-Small Cell Lung Cancer:

NSCLC accounts for most lung cancers. It includes several subtypes, with the three major forms being adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.

Adenocarcinoma begins in cells that line the alveoli and produce substances such as mucus. It is the most common subtype of NSCLC and can occur in people who have never smoked.

Squamous cell carcinoma develops from cells lining the airways and has a stronger association with cigarette smoking than some other NSCLC subtypes.

Large cell carcinoma is made up of large abnormal cells and can develop in different parts of the lung.

Other less common forms of NSCLC also exist, so pathology testing is important for identifying the specific cancer type.

Small Cell Lung Cancer:

Small cell lung cancer is less common than NSCLC but can grow and spread quickly. Smoking is the major risk factor associated with SCLC.

SCLC is generally classified as either limited-stage or extensive-stage disease based on how far the cancer has spread. Treatment decisions depend on the stage and other factors related to an individual’s health and cancer characteristics.

What Are the Symptoms of Lung Cancer?

The symptoms of lung cancer can vary from person to person. Some people have no noticeable symptoms during the early stages, while others may experience respiratory or general health changes.

Common symptoms may include:

• A cough that does not go away or becomes worse.
• Coughing up blood or rust-colored mucus.
• Chest pain or discomfort, particularly when breathing deeply, coughing, or laughing.
• Shortness of breath.
• New or persistent wheezing.
• Hoarseness.
• Loss of appetite.
• Unexplained weight loss.
• Persistent fatigue or weakness.
• Repeated respiratory infections, such as bronchitis or pneumonia.

These symptoms do not necessarily mean someone has cancer. Conditions such as infections, asthma, chronic respiratory diseases, and other health problems can cause similar symptoms.

However, persistent or unexplained changes should be discussed with a healthcare professional. Early evaluation can help determine whether additional testing is appropriate.

Signs of Lung Cancer That May Appear After It Spreads

As cancer progresses, symptoms may depend on where it has spread. For example, cancer that spreads outside the lungs can cause symptoms related to the affected area.

Possible symptoms may include:

• Bone pain.
• Headaches or neurological changes.
• Swelling in the face or neck.
• Enlarged lymph nodes.
• Unexplained weakness.
• Changes in appetite or weight.

The presence of one or more of these symptoms does not establish a cancer diagnosis. Medical evaluation and appropriate diagnostic testing are necessary.

What Causes Lung Cancer?

There is not one cause behind every case of lung cancer. Instead, several factors can increase a person’s risk. Smoking remains the strongest known risk factor, but lung cancer can also occur in people who have never smoked.

Important risk factors include:

Tobacco Smoke:

Cigarette smoking is the leading risk factor for lung cancer. Cigar and pipe smoking can also increase risk. The risk generally increases with the amount and duration of tobacco exposure.

Second-hand Smoke:

People who do not smoke can still be exposed to cancer-causing substances through second-hand tobacco smoke.

Radon Exposure:

Radon is a naturally occurring radioactive gas that can accumulate inside buildings. Long-term exposure can increase lung cancer risk, particularly among people who smoke.

Workplace Exposures:

Exposure to substances such as asbestos, arsenic, chromium, nickel, and certain other workplace carcinogens may increase lung cancer risk.

Air Pollution:

Outdoor air pollution has also been associated with increased lung cancer risk, although its contribution is much smaller than that of tobacco smoking.

Personal or Family History:

Having a personal or family history of lung cancer may increase your risk, although researchers are still studying how inherited genetic factors and shared environmental exposures contribute to the disease.

If you’re wondering is lung cancer hereditary, understanding the role of family history and genetics can help you have more informed conversations with your healthcare provider about your individual risk.

How Is Lung Cancer Diagnosed?

If a healthcare professional suspects lung cancer, several tests may be used to investigate an abnormal finding or persistent symptoms.

The diagnostic process may include:

Imaging Tests:

Imaging tests can provide pictures of the lungs and surrounding structures. Depending on the situation, healthcare professionals may use chest X-rays, computed tomography (CT) scans, PET scans, or other imaging methods.

Biopsy:

A biopsy involves collecting a sample of tissue or cells so that they can be examined under a microscope. A biopsy is commonly used to confirm whether abnormal cells are cancerous and help determine the type of cancer.

Molecular and Biomarker Testing:

For some NSCLC patients, tumor testing can identify specific biomarkers or genetic changes that may help guide treatment decisions. NCI notes that biomarker testing is important because several treatments target specific molecular alterations in NSCLC.

Staging:

Once lung cancer has been diagnosed, additional tests may determine whether it has spread and how extensively. This process is called staging.

For NSCLC, stages generally range from stage 0 through stage IV, with the stage reflecting factors such as tumor size, lymph node involvement, and spread to distant parts of the body.

Lung Cancer Screening

Screening is different from diagnostic testing. Screening is intended to identify lung cancer in people who may be at increased risk but do not have symptoms.

The American Cancer Society recommends yearly low-dose CT screening for certain adults ages 50 to 80 who currently smoke or previously smoked and have at least a 20 pack-year smoking history. Eligibility should be discussed with a healthcare professional because screening has potential benefits, limitations, and risks.

Screening does not prevent lung cancer, but it may help detect cancer earlier in people who meet screening criteria.

Lung Cancer Treatment

The appropriate lung cancer treatment depends on several factors, including the type and stage of cancer, tumor characteristics, biomarker results, overall health, and treatment goals.

Treatment may involve one or several approaches.

Surgery:

Surgery may be considered when the cancer can be removed safely. For certain early-stage NSCLC cases, surgery can be an important treatment option. The type of operation depends on the tumor’s location and extent.

Radiation Therapy:

Radiation therapy uses high-energy radiation to damage cancer cells. It may be used as a primary treatment, after surgery, with chemotherapy, or to manage symptoms depending on the circumstances.

Chemotherapy:

Chemotherapy uses medicines that can destroy cancer cells or slow their growth. It may be used alone or together with other treatments.

Immunotherapy:

Immunotherapy helps the immune system recognize and respond to cancer. It is used for certain people with lung cancer depending on factors such as cancer type, stage, and biomarker results.

Targeted Therapy:

Targeted therapies are designed to act on specific proteins or molecular changes that help cancer cells grow and survive. For people whose tumors have targetable alterations, these treatments may offer another treatment option.

Combination Treatment:

Some patients receive more than one treatment. For example, treatment may combine chemotherapy with radiation, surgery with systemic therapy, or immunotherapy with other approaches. The treatment plan is individualized according to the cancer and the patient’s circumstances.

Treatment for Lung Cancer by Type and Stage

There is no single treatment for lung cancer that works for every patient.

For NSCLC, treatment can include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and other local treatments. The stage of the cancer and molecular characteristics can influence which options are considered.

SCLC is generally treated differently because of its tendency to grow and spread quickly. Chemotherapy and radiation therapy are important treatment approaches, while immunotherapy may also be used in certain settings.

A multidisciplinary cancer care team may include medical oncologists, radiation oncologists, surgeons, pulmonologists, pathologists, radiologists, nurses, and other healthcare professionals.

How to Prevent Lung Cancer?

There is no guaranteed way to prevent every case of lung cancer. However, reducing exposure to known risk factors can lower the risk.

1. Do Not Smoke:

Avoiding tobacco is one of the most important ways to reduce lung cancer risk. For people who smoke, quitting can lower risk over time, regardless of age or how long they have smoked.

2. Avoid Second-hand Smoke:

Reducing exposure to other people’s tobacco smoke can also help lower risk.

3. Test for Radon:

Testing homes and other indoor environments for radon can help identify elevated exposure. If high levels are found, appropriate measures can reduce indoor radon levels.

4. Reduce Workplace Exposure:

Following workplace safety practices and using appropriate protective equipment can help reduce exposure to known carcinogens.

5. Discuss Screening with Your Healthcare Provider:

People at higher risk may benefit from discussing lung cancer screening with a healthcare professional. Screening recommendations are based on factors such as age and smoking history.

It is important to remember that prevention measures reduce risk; they cannot guarantee that someone will never develop cancer.

The Role of Lung Cancer Research Studies

Medical research continues to investigate better ways to prevent, diagnose, and treat lung cancer. Researchers are studying new medicines, treatment combinations, biomarkers, immunotherapies, targeted therapies, screening approaches, and other strategies.

People interested in contributing to medical progress may explore Lung Cancer research studies to learn about opportunities that may be available.

Clinical studies have specific eligibility requirements. These may include cancer type, stage, previous treatment, age, overall health, laboratory findings, and other factors.

Clinical Trials and Lung Cancer Research

Clinical research plays an important role in evaluating potential new approaches to cancer care. Depending on the study, researchers may investigate an experimental medication, a new treatment combination, a diagnostic approach, a supportive-care strategy, or another intervention.

People considering a study should receive information about the study’s purpose, procedures, potential benefits and risks, eligibility criteria, and alternatives before deciding whether to participate.

Those interested in Clinical Trials Recruitment can speak with a qualified research team to determine whether an available study may be appropriate for them.

Ongoing Research Studies and Future Treatment Options

Lung cancer research continues to evolve as scientists learn more about the biological changes that drive different tumors. Research is increasingly focused on matching treatments to specific characteristics of an individual’s cancer.

Researchers are also investigating ways to detect lung cancer earlier, improve treatment effectiveness, reduce treatment-related side effects, and develop options for cancers that do not respond adequately to existing therapies.

People looking for Ongoing research studies should review the eligibility criteria carefully and discuss participation with their healthcare provider and the study team.

Participation in a clinical study is voluntary. Being interested in a trial does not guarantee eligibility or enrollment, and a research team determines eligibility according to the study protocol.

Final Thoughts

Understanding lung cancer begins with knowing its possible symptoms, risk factors, major types, and available treatment approaches. Persistent respiratory symptoms or unexplained changes in health should be discussed with a healthcare professional rather than assumed to be cancer or another specific condition.

If you are interested in participating in research, exploring Lung Cancer research studies at Hightower Clinical Research may provide information about potential opportunities.